Clinical Trial Update: Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetics study of single doses of PNU-100480 in healthy adults has completed, providing initial safety and PK data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• PNU-100480

Snippet

Sponsor: Sequella, Inc. | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED